Tech Company Financing Transactions
Alexar Therapeutics Funding Round
Alexar Therapeutics, based in Malvern, secured $21.5 million in funding from New Science Ventures, Third Point and Palo Alto Investors.
Transaction Overview
New Science Ventures (Lead Investor) (Somu Subramaniam)
Third Point (Lead Investor) (Jason Hong)
Company Information
Malvern, PA 19355
USA
Management Team
Browse more venture capital transactions:
Prev: 1/3/2014: Spredfast venture capital transaction
Next: 1/4/2014: ZeroTurnaround venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs